Vimarsana
Biggest News Aggregation in the World

Page 46 - Sofinnova Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sofinnova Partners Today - Breaking & Trending Today

Sphere Fluidics Strengthens Commercial Team With Three New Senior Hires - Vimarsana News

Sphere Fluidics Strengthens Commercial Team With Three New Senior Hires

Evelyn Stevenson joins as Director of Product Management, Ravi Girdhar as Director of Sales in the EMEA region, and Denise Emsden as Vice-President of People and Organizational Development

Sofinnova Partners: GFBiochemicals raises €15m Series A to Advance its Mission to End Chemical Pollution - Vimarsana News

Sofinnova Partners: GFBiochemicals raises €15m Series A to Advance its Mission to End Chemical Pollution

The round is led by Sofinnova Partners with the support of Sparta CapitalCo-founder and environmental entrepreneur, Mathieu Flamini, appointed CEO to accelerate the transition towards safer and more sustainable

GlycoEra AG Appoints Ganesh V. Kaundinya as President and Chief Executive Officer - Vimarsana News

GlycoEra AG Appoints Ganesh V. Kaundinya as President and Chief Executive Officer

/PRNewswire/ -- GlycoEra AG announced today the appointment of Ganesh V. Kaundinya, Ph.D. as President and Chief Executive Officer. Dr. Kaundinya has been a...

Catamaran Bio to Present Preclinical Data at ASGCT Annual Meeting to Support CAR-NK Approach for Sol - Vimarsana News

Catamaran Bio to Present Preclinical Data at ASGCT Annual Meeting to Support CAR-NK Approach for Sol

– Two posters describe features of Catamaran’s CAR-NK platform designed to overcome the immunosuppressive effects of the solid tumor microenvironment –CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catamaran Bio, Inc., a biotechnology company developing off‑the-shelf chimeric antigen receptor (CAR)-NK cell therapies to treat ca...

Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases - Vimarsana News

Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases

Press release content from Accesswire. The AP news staff was not involved in its creation.

Source: apnews.com